Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operations
ABPWW logo

Abpro's Net Loss Surges 119% to $8.5M Amid Cash Crunch

ABPWW10-QFiling Date: 11/14/2025
Abpro Holdings, Inc.
Description

What this story covers

Abpro Holdings, Inc. reported a $1.7M Q3 net loss, up 21% YoY, with nine-month losses at $8.5M due to rising G&A costs and zero revenue. R&D slashed 64% via furloughs to conserve $328K cash, raising going concern doubts. Pipeline advances like ABP-102 Phase 1/2 in 2026 hinge on funding from SEPA conversions and partnerships with Celltrion and others, amid Nasdaq compliance risks.

Story snapshot

CompanyAbpro Holdings, Inc.
TickerABPWW
VariantStandard detailed
Duration16:34
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0001213900-25-110972

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in